Galapagos ROA 2013-2020 | GLPG

Current and historical return on assets (ROA) values for Galapagos (GLPG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Galapagos ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.41B $6.69B -6.10%
2020-06-30 $0.09B $6.44B 1.41%
2020-03-31 $0.17B $6.61B 3.12%
2019-12-31 $0.17B $6.80B 4.09%
2019-09-30 $0.31B $6.51B 11.09%
2019-06-30 $-0.07B $1.53B -4.34%
2019-03-31 $-0.04B $1.59B -2.73%
2018-12-31 $-0.04B $1.70B -2.20%
2018-06-30 $-0.09B $1.44B -6.11%
2018-03-31 $-0.02B $1.51B -1.54%
2017-03-31 $-0.07B $1.19B -8.04%
2016-03-31 $-0.08B $1.19B -10.97%
2015-12-31 $-0.13B $0.49B -33.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.575B $1.004B
Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $146.464B 10.44
Amgen (AMGN) United States $138.405B 14.47
CSL (CSLLY) Australia $96.318B 0.00
Gilead Sciences (GILD) United States $77.142B 10.26
Vertex Pharmaceuticals (VRTX) United States $59.055B 27.46
Regeneron Pharmaceuticals (REGN) United States $54.623B 19.38
Illumina (ILMN) United States $52.852B 72.69
Moderna (MRNA) United States $49.092B 0.00
Biogen (BIIB) United States $41.036B 7.29
Alexion Pharmaceuticals (ALXN) United States $34.236B 13.64
Seagen (SGEN) United States $31.962B 84.14
BeiGene (BGNE) Cayman Islands $28.201B 0.00
Genmab (GMAB) Denmark $28.073B 33.20
Genmab (GNMSF) Denmark $26.488B 6.10
BioNTech SE (BNTX) Germany $23.217B 0.00
Exact Sciences (EXAS) United States $21.867B 0.00
Incyte (INCY) United States $20.310B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.859B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Horizon Therapeutics Public (HZNP) Ireland $17.017B 24.32
Guardant Health (GH) United States $15.932B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.875B 98.72
CRISPR Therapeutics AG (CRSP) Switzerland $13.803B 0.00
ARGENX SE-ADR (ARGX) Netherlands $12.974B 0.00
Bio-Techne Corp (TECH) United States $12.763B 81.63
QIAGEN (QGEN) Netherlands $12.146B 27.35
Repligen (RGEN) United States $10.943B 155.20
Mirati Therapeutics (MRTX) United States $10.155B 0.00
Fate Therapeutics (FATE) United States $9.884B 0.00
Denali Therapeutics (DNLI) United States $9.138B 0.00
Ascendis Pharma (ASND) Denmark $8.840B 0.00
Adaptive Biotechnologies (ADPT) United States $8.684B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.475B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.223B 0.00
Twist Bioscience (TWST) United States $8.187B 0.00
Novavax (NVAX) United States $8.035B 0.00
Exelixis (EXEL) United States $7.561B 50.77
Acceleron Pharma (XLRN) United States $7.431B 0.00
Sarepta Therapeutics (SRPT) United States $6.883B 0.00
Halozyme Therapeutics (HALO) United States $6.101B 282.06
Amicus Therapeutics (FOLD) United States $5.988B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.964B 17.44
NeoGenomics (NEO) United States $5.863B 1760.33
Blueprint Medicines (BPMC) United States $5.794B 19.18
Emergent Biosolutions (EBS) United States $5.705B 18.72
Beam Therapeutics (BEAM) United States $5.677B 0.00
Certara (CERT) United States $5.097B 0.00
Eidos Therapeutics (EIDX) United States $4.702B 0.00
China Biologic Products (CBPO) China $4.638B 30.06
Editas Medicine (EDIT) United States $4.569B 0.00
Arena Pharmaceuticals (ARNA) United States $4.555B 0.00
Vir Biotechnology (VIR) United States $4.529B 0.00
Intellia Therapeutics (NTLA) United States $4.491B 0.00
Reata Pharmaceuticals (RETA) United States $4.118B 0.00
Arvinas (ARVN) United States $3.990B 0.00
MorphoSys AG (MOR) Germany $3.751B 135.76
Legend Biotech (LEGN) United States $3.709B 0.00
Insmed (INSM) United States $3.706B 0.00
Alkermes (ALKS) Ireland $3.473B 34.09
Bluebird Bio (BLUE) United States $3.285B 0.00
Global Blood Therapeutics (GBT) United States $3.031B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.940B 0.00
I-Mab (IMAB) China $2.907B 0.00
Intra-Cellular Therapies (ITCI) United States $2.713B 0.00
Zymeworks (ZYME) Canada $2.427B 0.00
Seres Therapeutics (MCRB) United States $2.360B 0.00
Amarin (AMRN) Ireland $2.331B 0.00
Arcus Biosciences (RCUS) United States $2.316B 0.00
Sangamo Therapeutics (SGMO) United States $2.192B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.189B 0.00
Viela Bio (VIE) United States $1.988B 0.00
Revance Therapeutics (RVNC) United States $1.928B 0.00
Sorrento Therapeutics (SRNE) United States $1.912B 0.00
Genetron Holdings (GTH) China $1.878B 0.00
Myriad Genetics (MYGN) United States $1.867B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.849B 15.30
Scholar Rock Holding (SRRK) United States $1.799B 0.00
Ligand Pharmaceuticals (LGND) United States $1.788B 46.33
REGENXBIO (RGNX) United States $1.774B 0.00
NGM Biopharmaceuticals (NGM) United States $1.774B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.768B 0.00
PHARMA MAR SA (PHMMF) Spain $1.746B 0.00
UniQure (QURE) Netherlands $1.692B 0.00
Vericel (VCEL) United States $1.677B 0.00
NantKwest (NK) United States $1.605B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.563B 0.00
Precigen (PGEN) United States $1.562B 0.00
Zealand Pharma (ZEAL) Denmark $1.493B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.477B 0.00
Castle Biosciences (CSTL) United States $1.474B 0.00
Heska (HSKA) United States $1.441B 0.00
Travere Therapeutics (TVTX) United States $1.439B 0.00
Codexis (CDXS) United States $1.381B 0.00
Cytokineticsorporated (CYTK) United States $1.364B 0.00
Mersana Therapeutics (MRSN) United States $1.310B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Antibe Therapeutics (ATBPF) Canada $1.256B 0.00
Cellectis S.A (CLLS) France $1.243B 0.00
Coherus BioSciences (CHRS) United States $1.242B 8.21
Alector (ALEC) United States $1.212B 0.00
Mesoblast (MESO) Australia $1.192B 0.00
Epizyme (EPZM) United States $1.171B 0.00
Frequency Therapeutics (FREQ) United States $1.165B 0.00
Northwest Biotherapeutics (NWBO) United States $1.152B 0.00
Adverum Biotechnologies (ADVM) United States $1.109B 0.00
MiMedx (MDXG) United States $1.011B 0.00
Athenex (ATNX) United States $0.997B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.987B 0.00
Pliant Therapeutics (PLRX) United States $0.983B 0.00
Sutro Biopharma (STRO) United States $0.979B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.957B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.943B 0.00
Morphic Holding (MORF) United States $0.939B 0.00
Pharming Group (PHGUF) Netherlands $0.920B 24.50
Compugen (CGEN) Israel $0.918B 0.00
Cara Therapeutics (CARA) United States $0.871B 0.00
Bionano Genomics (BNGO) United States $0.862B 0.00
Protagonist Therapeutics (PTGX) United States $0.816B 0.00
Avid Bioservices (CDMO) United States $0.771B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.766B 38.89
Adaptimmune Therapeutics (ADAP) United Kingdom $0.757B 0.00
VBI Vaccines (VBIV) United States $0.746B 0.00
Kadmon Holdings (KDMN) United States $0.736B 0.00
MannKind (MNKD) United States $0.735B 0.00
Albireo Pharma (ALBO) United States $0.707B 0.00
Celldex Therapeutics (CLDX) United States $0.695B 0.00
Syros Pharmaceuticals (SYRS) United States $0.688B 0.00
AnaptysBio (ANAB) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.651B 0.00
Merus (MRUS) Netherlands $0.643B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Affimed (AFMD) Germany $0.636B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.628B 0.00
Curis (CRIS) United States $0.620B 0.00
Cardiff Oncology (CRDF) United States $0.619B 0.00
MeiraGTx Holdings (MGTX) United States $0.618B 0.00
Agenus (AGEN) United States $0.607B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.606B 0.00
Five Prime Therapeutics (FPRX) United States $0.569B 0.00
Anika Therapeutics (ANIK) United States $0.568B 76.89
Dynavax Technologies (DVAX) United States $0.561B 0.00
Prothena (PRTA) Ireland $0.543B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.541B 0.00
Pandion Therapeutics (PAND) United States $0.540B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.535B 0.00
Cel-Sci (CVM) United States $0.525B 0.00
Precision BioSciences (DTIL) United States $0.514B 0.00
Geron (GERN) United States $0.503B 0.00
Clovis Oncology (CLVS) United States $0.496B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.475B 0.00
FORTE BIOSCIENC (FBRX) United States $0.469B 0.00
Starpharma Holdings (SPHRY) Australia $0.467B 0.00
AquaBounty Technologies (AQB) United States $0.465B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.460B 0.00
Amryt Pharma (AMYT) United Kingdom $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.452B 21.29
XOMA (XOMA) United States $0.446B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.445B 0.00
Spero Therapeutics (SPRO) United States $0.437B 0.00
WAVE Life Sciences (WVE) Singapore $0.432B 0.00
AMMO (POWW) United States $0.431B 0.00
Puma Biotechnology (PBYI) United States $0.429B 0.00
UROGEN PHARMA (URGN) United States $0.424B 0.00
Kala Pharmaceuticals (KALA) United States $0.421B 0.00
AC Immune SA (ACIU) Switzerland $0.415B 0.00
DBV Technologies S.A (DBVT) France $0.410B 0.00
Verastem (VSTM) United States $0.402B 0.00
ANI Pharmaceuticals (ANIP) United States $0.393B 10.00
Athersys (ATHX) United States $0.384B 0.00
Cue Biopharma (CUE) United States $0.383B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.379B 0.00
Innate Pharma S.A (IPHA) France $0.371B 0.00
Selecta Biosciences (SELB) United States $0.362B 0.00
CytomX Therapeutics (CTMX) United States $0.355B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.351B 0.00
Trevena (TRVN) United States $0.349B 0.00
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Arbutus Biopharma (ABUS) United States $0.343B 0.00
NextCure (NXTC) United States $0.333B 0.00
Fortress Biotech (FBIO) United States $0.324B 0.00
Voyager Therapeutics (VYGR) United States $0.321B 8.24
Kamada (KMDA) Israel $0.314B 14.71
Lineage Cell Therapeutics (LCTX) United States $0.306B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
CorMedix Inc (CRMD) United States $0.277B 0.00
Bellus Health (BLU) Canada $0.265B 0.00
IBio (IBIO) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.236B 0.00
Cogent Biosciences (COGT) United States $0.232B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.231B 0.00
Aptinyx (APTX) United States $0.230B 0.00
Gritstone Oncology (GRTS) United States $0.218B 0.00
Checkpoint Therapeutics (CKPT) United States $0.212B 0.00
Exicure (XCUR) United States $0.210B 0.00
Eton Pharmaceuticals (ETON) United States $0.209B 0.00
Pluristem Therapeutics (PSTI) Israel $0.208B 0.00
GENFIT S.A (GNFT) France $0.207B 0.00
Cerecor (CERC) United States $0.205B 0.00
Biofrontera AG (BFRA) Germany $0.205B 0.00
TELA Bio (TELA) United States $0.202B 0.00
Theratechnologies (THTX) Canada $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.198B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
VolitionRX (VNRX) United States $0.196B 0.00
ADMA Biologics Inc (ADMA) United States $0.195B 0.00
Kindred Biosciences (KIN) United States $0.191B 0.00
Clearside Biomedical (CLSD) United States $0.191B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Palatin Technologies (PTN) United States $0.180B 0.00
DiaMedica Therapeutics (DMAC) United States $0.180B 0.00
Lumos Pharma (LUMO) United States $0.179B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Idera Pharmaceuticals (IDRA) United States $0.151B 0.00
Aptevo Therapeutics (APVO) United States $0.149B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.148B 0.00
Dyadic (DYAI) United States $0.145B 0.00
Evogene (EVGN) Israel $0.143B 0.00
TRACON Pharmaceuticals (TCON) United States $0.142B 0.00
Prima BioMed (IMMP) Australia $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.139B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
Protalix BioTherapeutics (PLX) Israel $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.124B 257.00
Ecology Coatings (ABVC) United States $0.123B 0.00
Cyclerion Therapeutics (CYCN) United States $0.122B 0.00
Prometic Life Sciences (LMNL) Canada $0.119B 0.00
AIT Therapeutics (XAIR) United States $0.118B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
Applied Genetic Technologies (AGTC) United States $0.116B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Synlogic (SYBX) United States $0.111B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Vascular Biogenics (VBLT) Israel $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Novogen (KZIA) Australia $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.090B 0.00
Aytu Bioscience (AYTU) United States $0.090B 0.00
Organovo Holdings (ONVO) United States $0.088B 0.00
MiRagen Therapeutics (MGEN) United States $0.087B 0.00
Stealth BioTherapeutics (MITO) United States $0.081B 38.75
CollPlant Holdings (CLGN) Israel $0.079B 0.00
Seelos Therapeutics (SEEL) United States $0.077B 0.00
CytRx (CYTR) United States $0.075B 0.00
Adocia (ADOCY) France $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Purple Biotech (PPBT) Israel $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.067B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Genetic Technologies (GENE) Australia $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Happiness Biotech Group (HAPP) China $0.056B 0.00
Yumanity Therapeutics (YMTX) United States $0.056B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.055B 0.00
Vaccinex (VCNX) United States $0.054B 0.00
Edesa Biotech (EDSA) Canada $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.051B 0.00
Cleveland BioLabs (CBLI) United States $0.049B 0.00
Acorda Therapeutics (ACOR) United States $0.049B 0.00
Advaxis (ADXS) United States $0.045B 0.00
BioCardia (BCDA) United States $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
AEterna Zentaris (AEZS) United States $0.043B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.043B 0.00
Chanticleer Holdings (SONN) United States $0.042B 0.00
Soligenix (SNGX) United States $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Spherix (AIKI) United States $0.039B 0.00
IMMURON (IMRN) Australia $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.036B 0.00
Celsion (CLSN) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Neuralstem (SNCA) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
CTD Holdings (CYTH) United States $0.009B 0.00
Enveric Biosciences (ENVB) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00